Timothy Parton studied Economics and Accounting at the University and graduated in 1986. He is a managing director and a portfolio manager within the JPMorgan Asset Management U.S. Equity Group. An employee since 1986, Tim has managed a variety of Small, Mid and All-Cap portfolios over his career. Tim has been managing the J.P. Morgan Mid Cap Growth strategy since November 2001 and the J.P. Morgan Growth Advantage strategy since its inception in September 2005. In addition, Tim is a co-portfolio manager of the J.P. Morgan Equity Focus strategy, the JPMorgan American Investment Trust and the J.P. Morgan Mid Cap Equity strategy.

Tim holds a B.Sc. in Economics & Accounting from the University of Bristol. He is a member of the New York Society of Security Analysts and The CFA Institute and is a CFA charter holder. In addition to serving on the board of the University of Bristol US Foundation, Tim is a director of African People & Wildlife, a conservation organization based in northern Tanzania with activities in southern Africa.

Geraldine is co-head of Investment Banking for the Midwest Region and a member of the Industrials Group within the Investment Banking Division. She joined Goldman Sachs in 2000 as an analyst on the UK Advisory team in London and transferred to the Industrials Group in San Francisco in 2004. After leaving in 2006 to pursue an MBA, Geraldine rejoined the firm in 2008 as a member of the Americas Special Situations Group in the Securities Division in New York, where she worked on minority equity investments in privately owned businesses. She returned to the Industrials Group in 2009 and was named vice president the same year.

Geraldine was named managing director in 2013 and partner in 2016. Geraldine serves on the Board of Trustees of the Chicago Symphony Orchestra, on the Posse Foundation Chicago Advisory Board and on the board of the University of Bristol US Foundation. She is also a member of the Civic Committee of the Commercial Club of Chicago. Geraldine earned a master’s degree in Aerospace Engineering from the University of Bristol in 2000 and an MBA, with high distinction, from Harvard Business School in 2008.

Dr. Una Ryan has extensive experience leading public, private and non-profit companies. She serves on the boards of Cortexyme (CRTX), RenovoRx (RNXT), Elemental Machines, Cambridge in America and the University of Bristol US Foundation. Dr. Ryan is an LP at Breakout Ventures and Lionheart Ventures. She focuses on women-led ventures as Managing Director of Golden Seeds, and partner in Astia Angels. She has a portfolio of early-stage companies in San Francisco and Boston.

She was a serial CEO of Diagnostics for All, Waltham Technologies and AVANT (now CLDX).  Continuing a career translating science to successful businesses, Dr. Ryan is now translating science to art and founded ULUX bringing science perspectives to the art world.

Dr. Ryan holds a PhD from Cambridge University, BSc degrees and an honorary DSc from the University of Bristol. Her academic career included Professorships of Medicine at Miami, Washington and Boston Universities. She held the titles Howard Hughes Investigator, American Heart Association Established Investigator, and NIH MERIT Awardee. She received numerous honors including Albert Einstein Award for outstanding achievement in the life sciences, Cartier Award, World Economic Forum Tech Pioneer and Order of the British Empire (OBE).

After graduating from the University of Bristol in 1978, Tim joined Barclays Bank International. His banking career continued until 2010 and included time in the US (Boston and New York) and London. He set up the bank’s loan syndications team in New York and moved to London in 1994 to become global head of loan syndications. Later known as Global Loans, this business grew within Barclays Capital to take responsibility for the execution and distribution of corporate and leveraged loans originated by the Barclays Group, as well as loan trading and structured trade finance, and worked closely with the bank’s loan portfolio managers. During this period, Tim spent time on the Management Committee of Barclays Capital and served as Chairman of the Wholesale Committee of the British Bankers Association.

Tim was also the founding chairman of the Loan Market Association, a position which he held from 1996 to 2005. The Loan Market Association, which recently celebrated its 25th anniversary, is the trade body for the EMEA syndicated loan market and now has over 750 member institutions, including banks, institutional investors, borrowers, law firms, rating agencies and other service providers.

Tim retired from Barclays in 2010 and his primary residence is on Cape Cod. He enjoys playing tennis and golf regularly. He and his wife Judi are collectors of contemporary art and have a close affiliation with the School of the Museum of Fine Arts, which is now part of Tufts University. Tim also serves on the school’s Advisory Board.

Leslie graduated from Bristol with a first class honours degree in mathematics. She continued her studies at the University of Michigan with a MS of Computer Science and holds an MSc of Business from Pace University.

Leslie began her career as a systems engineer at Bell Laboratories, progressing into senior roles in software-related businesses at Bell Laboratories, AT&T and NCR. After leaving AT&T, Leslie joined Stevens Institute of Technology as Industry Professor in the School of Systems and Enterprises and taught online graduate students in Systems Engineering for over 10 years, retiring in January 2020. For the last 7 years, Leslie has been involved in combating climate change with organisations 350nyc.org and Climate Reality, with a particular focus on transport systems for New York City.

Leslie lives in New Jersey. She was a director for the Farmstead Arts Center, a historic property now used as a local arts center. She was elected to the Bernards Township Board of Education as well as the boards for the Cancer Hope Network and the Wall Street Technology Association. She also enjoys playing the guitar, the arts, fitness and reading.    

Matt is the Chief Financial Officer of the Icahn School of Medicine at Mount Sinai, a role he assumed in 2021, having previously been the Chief Operating Officer of Mount Sinai Doctors Faculty Practice. Prior to these roles Matt was the co-founder and CFO of Sema4, a genetic testing and healthcare data company,and alsospent over 10 years at PricewaterhouseCoopers, providing advisory services to corporate and private equity clients.

Matt graduated from the University of Bristol in 2001 with a BSc in Economics and Politics and subsequently earned an MBA from NYU Stern School of Business and a CFA charter. In addition to the University of Bristol Foundation, Matt serves on the board of the Biomedical Research Association of New York, The Mitral Foundation and Castlevax. Matt lives in Westchester County, New Yorkand enjoys playing soccer, tennis and platform tennis.

Ben Quarmby is a partner with the litigation boutique of MoloLamken LLP.  He focuses on busine disputes and intellectual property litigation and has represented clients as lead trial counsel in federal and state trial courts around the United States.  His clients include US corporations, individuals and family offices, as well as many foreign companies, particularly from Japan and France.

Ben teaches US intellectual property law at the International Centre for Intellectual Property Studies (CEIPI) in France. He frequently publishes on topics including patent, trademark and trade secret law as well as art law, fashion law, the General Data Protection Regulation (GDPR), artificial intelligence, social media, and privacy. He is also a regular speaker on issues such as third-party litigation funding, developments in patent, trademark and copyright law, and international arbitration.

In addition to serving as a Director for the University of Bristol Foundation, Ben also serves on the New York University Langone Family Advisory Council and its Diabetes Family Advisory Council. He is interested in all issues relating to Type 1 diabetes- medical, technological, social and beyond.